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Abstract K+ channels composed of GIRK subunits are
predominantly expressed in the heart and various regions of the
brain. They are activated by LQ-subunits released from pertussis
toxin-sensitive G-proteins coupled to different seven-helix
receptors. In rat atrial myocytes, activation of KACh channels
is strictly limited to receptors coupled to pertussis toxin-sensitive
G-proteins. Upon treatment of myocytes with antisense oligode-
soxynucleotides against GRK2, a receptor kinase with GLQ
binding sites, in a fraction of cells, KACh channels can be
activated by L-adrenergic receptors. Sensitivity to L-agonist is
insensitive to pertussis toxin treatment. These findings demon-
strate a potential role of GLQ binding proteins for target
selectivity of G-protein-coupled receptors
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1. Introduction
An important pathway controlling the membrane excitabil-
ity in cardiac and neuronal cells is the regulation of K ion
channel activity by receptors for neurotransmitters or hor-
mones via heterotrimeric G-proteins in a membrane-delimited
fashion (for reviews see [1,2]). The prototype of this ion chan-
nel family is the muscarinic K (KACh) channel predomi-
nantly expressed in supraventricular myocytes. It is composed
of two related subunits (GIRK1/GIRK4, also termed Kir3.1/
Kir3.4) [3], which form a heterotetramer. It is now commonly
accepted that channel gating is directly controlled by physical
interaction of the GIRK subunits with GLQ [4^7]. In the heart,
KACh channels can be activated by di¡erent receptors that
couple to pertussis toxin (Ptx)-sensitive G-proteins, such as
M2 muscarinic, A1 purinergic [8] and a sphingolipid receptor
with a high a⁄nity to sphingosine-1-phosphate [9,10]. In ex-
cised inside-out membrane patches, KACh channels can be
activated by a number of di¡erent GLQ combinations [4,11],
as would be expected given that the speci¢city of LQ-hetero-
dimers to target proteins is weak [12]. In atrial myocytes,
activation of KACh channels is usually limited to receptors
coupled to Ptx-sensitive G-proteins [13]. In this regard, GIRK
channels expressed in oocytes behave di¡erently. They can be
activated by co-expressed L2-adrenergic receptors [14]. This
¢nding suggests that in the oocyte expression system, unlike
in a post-mitotic di¡erentiated cardiac myocyte, G-protein LQ-
subunits are promiscuously coupled to the GIRK channels.
Recently, [15] described a low incidence of Ptx-insensitive
activation of IKACh by isoprenaline in native canine atrial
myocytes which was enhanced by adenoviral infection. The
latter had been described previously to result in a non-speci¢c
increase in Gs. We have found recently a Ptx-insensitive acti-
vation of IKACh by isoprenaline in rat atrial myocytes over-
expressing a G-protein L1-subunit [13]. This ¢nding was inter-
preted by assuming that the overexpressed (inactive)
L-subunits might saturate proteins with GLQ binding motifs
which might act as ‘LQ-scavengers’, thereby limiting the spatial
spreading of LQ released upon receptor activation.
In the present study, the expression level of GRK2, a re-
ceptor kinase with a LQ binding sequence was inhibited in
post-mitotic (‘adult’) atrial myocytes, using an antisense ap-
proach. In the majority of cells treated with GRK2 antisense
ODN’s, KACh channels were activated by the L-adrenergic
agonist isoprenaline in a Ptx-insensitive fashion. The require-
ment for a normal expression level of GRK2 to maintain the
target speci¢city in a receptor-coupled signaling pathway sug-
gests a novel role of this protein in cellular signaling.
2. Materials and methods
2.1. Isolation and culture of atrial myocytes
WKY rats of either sex weighing around 200 g were anesthesized by
intravenous injection of urethan (1 g/kg). The chest was opened and
the heart was removed and mounted on the cannula of a Langendor¡
apparatus for coronary perfusion at a constant £ow. The method of
enzymatic isolation of atrial myocytes and culture conditions have
been described in detail previously [16]. Cells were plated at a low
density (several hundred cells per dish) on 36 mm culture dishes. The
medium was changed 24 h after plating and then every second day.
Cells were used experimentally from about 4 h after isolation up to
6 days in culture.
2.2. Solutions and chemicals
For the patch-clamp measurements, an extracellular solution of the
following composition was used (mM): NaCl 120, KCl 20, CaCl2 2.0,
MgCl2 1.0, HEPES/NaOH 10.0, pH 7.4. The solution for ¢lling the
patch-clamp pipettes for whole-cell voltage clamp experiments con-
tained (mM) K-aspartate 110, KCl 20, NaCl 10, MgCl2 1.0, MgATP
2.0, EGTA 2.0, GTP 0.01, HEPES/KOH 10.0, pH 7.4. The K equi-
librium potential under this condition is 350 mV. This experimental
condition was chosen because of the strongly inward rectifying prop-
erties of IKACh, which yields very small currents in the outward
direction, i.e. at a membrane potential positive to EK. In the majority
of experiments, this solution was supplemented with cAMP (100 WM)
to fully activate the cAMP-dependent signaling pathway. The ration-
ale for this was to exclude that the L-adrenergic e¡ects described here
were cAMP-dependent. Standard chemicals were from Merck (Darm-
stadt, Germany). EGTA, HEPES, MgATP, adenosine GTP and ACh-
chloride were from Sigma (Deisenhofen, Germany).
2.3. Current measurement
Membrane currents were measured by means of whole-cell voltage
patch-clamp. Pipettes were fabricated from borosilicate glass with
¢lament (Clark, Pangbourne, UK) and were ¢lled with the solution
listed above. The DC resistance of the ¢lled pipettes ranged from 2 to
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6 M6. Current measurements were performed by means of a patch-
clamp ampli¢er (List LM/EPC 7, Darmstadt, Germany) as described
in detail recently [13]. Experiments were performed at an ambient
temperature (22^24‡C). Cells were voltage-clamped at a holding po-
tential of 390 mV, i.e. negative to EK. K channel currents under this
condition are in the inward direction. This experimental condition was
chosen because of the strongly inward rectifying properties of IKACh.
Current-voltage relations were determined by means of a ramp pro-
tocol. From 390 mV, the holding potential was stepped to 3120 mV,
followed by a voltage ramp at 360 mV/s to +60 mV and a step back to
390 mV. Rapid application and withdrawal of di¡erent solutions was
performed by means of a solenoid-operated £ow system that permit-
ted switching between up to six di¡erent solutions. The half time of
exchange of solution seen by the superfused cell was less than 100 ms
and was not limiting the activation kinetics of IKACh:
2.4. Treatment with AsODNs
AsODNs (5P-CTTTTGGAAGATGTCG-3P) against nucleotides
480^495 of the rat GRK2 cDNA sequence were synthesized with
the phosphorothioate backbone by Biognostik (Go«ttingen, Germany).
As control ODN, a randomized sequence with the above DN compo-
sition was used. Antisense and control ODNs were diluted in M199
culture medium to a ¢nal concentration of 6 WM. Cells were incubated
on day 2 after plating for 3^5 days in 1 ml ODN-supplemented me-
dium. Optical monitoring the uptake of ODNs using a £uorescein tag
yielded a half time for loading in the order of 2 h. After 48 h, ODN
containing medium was replaced by standard medium. Measurements
were performed after another 24 or 48 days, i.e. on days 5 and 6 in
vitro. The rationale for using this time window was that on day 4,
no e¡ects were seen (n = 6), whereas after periods of time in vitro
s 7 days, an increasing number of cells developed vacuole-like struc-
tures. This did not a¡ect the viability, adult myocytes could be kept in
vitro for s 3 months, but impeded formation of stable Gigaohm
seals.
2.5. Western blots
For Western blots, 104 cells per dish were plated and incubated
with either control or AsODNs. On day 5, cells were harvested, pel-
leted and washed once in PBS. Each pellet was diluted and boiled for
10 min in 2USDS-Laemmli bu¡er followed by PAGE using a 12%
acrylamide (29:1) gel with a 6% stacking gel. Following electropho-
resis, proteins were blotted to a nylon membrane using the Electro-
Trans-Blot (Bio-Rad, Germany). The membrane was washed and
blocked according to the manufacturer’s protocol. Rabbit polyclonal
anti-GRK2 antibody (Santa Cruz Biotechnology, USA) was diluted in
blocking solution (1 Wg/ml), incubated with the membrane for 30 min
at room temperature and washed 3U5 min in H2O and once with
TBS. Alkaline phosphatase conjugated anti-rabbit IgG antibody was
diluted in blocking solution (1:6000) and incubated with the mem-
brane at room temperature for 30 min. GRK2-antibody complex was
detected using chemiluminescent substrate sheets (Schleicher and
Schuell, Germany).
3. Results and discussion
Fig. 1A shows changes in the membrane current induced by
rapid superfusion with ACh at a saturating concentration
(2 WM) of a myocyte, cultured for 6 days. The cell was treated
with control ODNs by incubation on day 2 after isolation. In
this and the subsequent experiments for about 5 min before
the trace was recorded, cAMP was allowed to di¡use into the
cell from the recording pipette. At the standard holding po-
tential (390 mV) and EK (350 mV), K channel currents are
in the inward direction. Repetitive brief exposures to ACh
resulted in inward currents of a reproducible amplitude.
From superimposed voltage ramps (3130^+60 mV), the cur-
rent-voltage relation of the ACh-activated current was ob-
tained by subtraction of the background I/V curve (Fig. 1B,
b3a). As in previous work, the I/V relation of this current is
characterized by strong inward recti¢cation, which is assumed
to result from a block by intracellular polyamines [17].
In line with a recent report [13], simultaneous superfusion
with the L-receptor agonist Iso at a highly saturating concen-
tration (10 WM) had no e¡ect on the holding current or on the
size of the ACh-induced current. Such a large concentration
was used to maximally activate L-adrenergic receptors. The
absence of an e¡ect of Iso is con¢rmed by the current-voltage
relations obtained by subtraction as indicated by the labelling.
Fig. 1B shows I/V curves of ACh-activated current in the
absence and presence of Iso. The two curves are perfectly
superimposable, demonstrating that there is no e¡ect of
L-adrenergic stimulation on M2 receptor-activated IKACh
under these experimental conditions. Fig. 1C shows the back-
ground current at a 390 mV holding potential in the presence
of Iso (c) minus control (a). The di¡erence is zero over the
entire range of membrane potentials. This behavior, i.e. a
complete lack of an e¡ect of Iso on the holding current and
receptor-activated IKACh, was found in 28/28 untreated cells
and 15/15 cells incubated with the control ODN. If cAMP was
omitted from the pipette ¢lling solution, identical results were
obtained with regard to the current under study (n = 6). Fur-
thermore, superfusion with forskolin (10 WM) had no e¡ect on
the holding current or the voltage ramp-induced current (not
Fig. 1. L-adrenergic stimulation does not interfere with the muscar-
inic signaling pathway in myocytes expressing normal levels of
GRK2. (A) Representative recording of the membrane current at a
390 mV holding potential from a myocyte treated with a random-
ized ODN sequence as described in Section 2. Rapid de£ections in
this and subsequent ¢gures represent changes in the membrane cur-
rent caused by a voltage ramp protocol shown in the inset. ACh
and Iso were superfused as indicated by the horizontal bars. (B)
(left panel) Current-voltage relations of ACh-activated current in
the absence (b-a) and in the presence (d-c) of isoprenaline. I/V
curves represent di¡erence currents obtained by background sub-
traction as indicated by the labelling. (B) (right panel) Subtraction
of the control background current (a) from the background current
in the presence of iso (c) yields zero over the whole range of mem-
brane potentials.
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shown). Consistent with previous studies of IKACh, there is
no [18] or little [15] direct cross-talk of the muscarinic and the
L-adrenergic signaling pathways with regard to this target in
native myocytes. This is in contrast to ¢ndings in the oocyte
system, where expressed GIRK subunits form functional
channels that can be substantially activated by co-expressed
L-adrenergic receptors [14]. We hypothesized that in di¡eren-
tiated cells, other proteins with LQ binding sites might a¡ect
the spatio-temporal distribution of free LQ-subunits upon re-
ceptor stimulation. Such a mechanism could contribute to
preventing an unphysiological interaction of GsLQ with the
GIRK1/GIRK4 subunits. One candidate for a protein that
could play this role is GRK2 (Lark1), a receptor kinase which
is activated and targeted to the membrane by binding to the
L-subunit of heterotrimeric G-proteins [19]. In order to test
this hypothesis, we used an AsODN directed against a part of
the encoding sequence of rat GRK2. Inhibition of expression
of GRK2 was veri¢ed by Western blot analysis, comparing
sister cultures 4 days after incubation with either the GRK2-
speci¢c or the scrambled sequence (see Section 2). An example
representative of three pairs of culture dishes is illustrated in
Fig. 2 (inset). Although the signals are weak due to the small
amount of material and do not permit a quantitative evalua-
tion of the di¡erence of GRK2 expression, the blots clearly
indicate a reduced amount of GRK2 in the antisense AsODN-
treated myocytes. A representative example of a recording of
the membrane current from a myocyte treated with the GRK2
AsODN is illustrated in Fig. 2A. The cell responded normally
to a saturating concentration of ACh (2 WM). During the
second challenge by ACh, superfusion was switched to a sol-
ution additionally containing the muscarinic antagonist atro-
pine (1 WM). This resulted in a complete inhibition of IKACh.
Iso (10 WM) in the continuous presence of atropine caused a
reversible and reproducible inward current of 350 pA. An
analysis of the current-voltage relation of the Iso-induced cur-
rent (Fig. 2C) yielded a curve which, after scaling up, was
perfectly superimposable on the I/V curve of the ACh-acti-
vated current. As activation of the current by Iso was insen-
sitive to a saturating concentration of atropine, a participa-
tion of M2 receptors in the Iso-activated current and so also
artefacts, e.g. leak of trace amounts of ACh from the super-
fusion device, can be safely excluded. Activation of the inward
rectifying K current ranging from v5%^22% of peak IKACh
induced by ACh was found in 70% (23 of 32) of GRK
AsODN-treated myocytes. The large variability is not surpris-
ing, given that neither cellular uptake of ODNs nor the re-
duction in expression of the protein are likely to be homoge-
nous in all cells in a dish. The concentration of Iso used in
these experiments (10 WM) is highly saturating and might even
cause unspeci¢c e¡ects. It should be noted, however, that the
same concentration of the agonist was completely ine¡ective
in 100% of the control cells.
The strongly inward rectifying I/V relation identi¢es the K
current induced by Iso as IKACh. This is further supported by
cross-desensitisation between the ACh- and Iso-activated cur-
Fig. 2. Activation of IKACh by isoprenaline in a myocyte treated
with GRK2 AsODN. (A) Recording of the membrane current at a
390 mV holding potential. ACh, atropine and isoprenaline were
superfused as indicated. The inset shows a representative immuno-
blot for rat GRK2 (molecular weight 76 kDa). Line 1 represents
GRK2-AsODN-treated culture; line 2, a sister culture treated with
control ODN. (B) Current-voltage relationship of the ACh-induced
current (a-b in A) and isoprenaline-induced current (d-c), multiplied
by a factor of 6.21 to match the size of the ACh-induced current at
3100 mV.
Fig. 3. Activation of IKACh by Iso in a myocyte pre-incubated with
pertussis toxin. (A) Membrane current at a 390 mV holding poten-
tial. ACh was used at a highly saturating concentration (10 WM).
(B) Di¡erence I/V relationship of the Iso-induced current. The up-
ward de£ections representing the ramp-induced outward current
have been cut o¡. The non-specifc leak current was signi¢cantly
larger after Ptx treatment, resulting in a more pronounced contami-
nation of background currents.
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rent using similar protocols as shown recently [13] (data not
shown). Coupling of receptors to KACh channels normally
proceeds via LQ-subunits of (a) Ptx-sensitive G-protein(s). If
activation of IKACh by Iso proceeds via Gs, it should be
insensitive to treatment with Ptx. As shown previously, recep-
tor-mediated activation of whole-cell IKACh in the system
under study can be completely abolished by incubation of
myocyte cultures with Ptx at 2 WM forV6 h. A representative
recording from a GRK2 antisense-treated Ptx-incubated cell
is illustrated in Fig. 3. ACh at the standard concentration of
2 WM failed to induce a signi¢cant current. Iso (10 WM)
caused activation of an inward current at a 90 mV holding
potential of about 140 pA, which by its voltage-dependence
(Fig. 3B) was identi¢ed as IKACh. This was found in three of
¢ve Ptx-treated myocytes which were completely insensitive to
ACh. In 5/5 myocytes from time-matched control cultures
treated with Ptx, no activation of IKACh by Iso was detected.
In excised inside-out patches, activation of KACh channels
by di¡erent LQ-subunit combinations has been demonstrated
[20], in line with the notion that speci¢city of di¡erent LQ-
heterodimers for target proteins is not particularly pro-
nounced. Together with the ¢nding that KACh channels ex-
pressed in Xenopus oocytes can be activated by co-expressed
L2-adrenergic receptors [14], this raises the question what pre-
vents activation of this channel by free GsLQ produced by
activation of L-adrenergic receptors in a di¡erentiated atrial
myocyte. As a matter of fact, Sorota et al. [15] recently de-
scribed that a fraction of acutely isolated or cultured canine
atrial myocytes at 37‡C showed a slight activation of IKACh
by Iso. This was insensitive to Ptx and thus most likely pro-
ceeded via LQ released from Gs. Increasing the concentration
of Gs by adenoviral infection caused a substantial increase in
sensitivity of IKACh to L-adrenergic stimulation. If the low
basal sensitivity of IKACh to Iso observed in a fraction of
cells in that study re£ects a species property or a combination
of several factors (species, temperature, etc.) at present is not
known. The ¢nding as such lends further support to the no-
tion that signaling via LQ-subunits in principle is promiscuous
in nature.
Although most of the actions of L-adrenergic receptors are
mediated through Gs-proteins and the cAMP system, few ex-
amples of Gi coupling of L2-R have been described. In the
heart, evidence based on pharmacological experiments for a
coupling of L2-R to Ptx-sensitive G-proteins has been pro-
vided [21]. More recently, [22], using a heterologous expres-
sion system, found that phosphorylation of L2 receptors by
PKA causes a switch in their coupling from Gs (Ptx-insensi-
tive) to Gi (Ptx-sensitive), resulting in activation of the MAP
kinase pathway in that model.
We can exclude an analogous mechanism as the basis of the
L-receptor-induced activation of IKACh in the present study
for two reasons: (i) L-receptor-induced IKACh is not sensitive
to Ptx and (ii) in control and AsODN-treated myocytes, intra-
cellular loading with cAMP and superfused with forskolin had
no e¡ect on the signaling pathway under study. Furthermore,
activation of IKACh by L-adrenergic stimulation was never
seen in a total of 43 control myocytes, either untreated or
incubated with the scrambled AsODN sequence.
Although LQ binding to GRK2 is a key step in mediating
homologous desensitization of various G-protein-coupled re-
ceptors (see [23,24] for reviews), this kinase is not a priori
selective for a distinct receptor. Speci¢city is assumed to result
from its targeting to an agonist-activated receptor by free LQ
[19]. This concept implies that the kinase is retained in the
micro-environment of an activated receptor by binding to LQ.
The binding site on GRK2 for the (L) subunit overlaps with a
pleckstrin homology (PH) domain at the C-terminus of
GRK2 [19,25,26]. PH domains are modules of around 100
amino acids that are found in a large number of proteins
(see [27] for reviews). Apart from an interaction motif for L-
subunits, they share a phosphoinositide binding site. It has
been demonstrated that GRK2 translocation to the membrane
and kinase activity require both binding to LQ and a phos-
phoinositide, presumably PIP2 [28]. It is conceivable that the
coordinated binding of GRK2 to two membrane-associated
ligands (PIP2 and GLQ ) contributes to limiting its lateral mo-
bility. Formation of such a complex, in turn, would also a¡ect
the lateral mobility of the ligand, i.e LQ. In this way, GRK2
could contribute to preventing interaction of LQ with a wrong
target protein. This interpretation is in line with our recent
observation that overexpressing a L-subunit in atrial myocytes
by transient transfection, apart from reducing the IKACh am-
plitude, renders this current sensitive to L-adrenergic stimula-
tion to about the same extent as in the present study [13].
It has been demonstrated that peptides derived from the C-
terminus of GRK2 (LARK1), containing the LQ binding se-
quence, inhibit agonist-dependent activity of heterologously
expressed as well as native cardiac KACh channels when ap-
plied to the internal face of the membrane in excised inside-
out membrane patches [29] and whole-cell recordings [15].
These ¢ndings not only underscore the role of LQ as activator
of this target but also demonstrate the LQ sequestering potency
of GRK2 and its putative physiological role in tuning the
availability of LQ subunits released from di¡erent G-proteins
to target proteins.
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